Pharmafile Logo
Pharmafocus logo
Advanced Search

UK

Showing 7 posts of 472 posts found.

UK clinical research is being transformed

April 4, 2008
Research and Development UK, clinical trials

Politicians have been talking, reports have been published, a series of initiatives have been launched and a fist full of …

Feature

UK clinical trials: on the mend?

September 26, 2007
Research and Development UK, clinical trials, global, research

How clinical research is organised in the UK is essential to the success of Britain's pharma industry, and to the …

Feature

NICE in the dock: what the judicial review means for pharma

April 16, 2007
Research and Development, Sales and Marketing NICE, UK, healthcare, judicial review

The National Institute for Health and Clinical Excellence (NICE) has been at the centre of controversy ever since its inception …

Feature

Learning from Northwick Park

February 19, 2007
Research and Development UK, biotech, clinical trials, drug safety

In December 2006, the official report on the Northwick Park incident was published. Although not the end of the affair, …

Feature

Identifying and nurturing talent in your salesforce

August 7, 2006
Sales and Marketing Schering-Plough, UK, sales, strategy

The aim of every company, pharma or otherwise, is to boost sales and take a greater market share. However, despite …

Feature

New UK headquarters for Bristol-Myers Squibb

December 5, 2005
Sales and Marketing BMS, UK

Bristol-Myers Squibb UK has moved into a new state-of-the-art head office in Uxbridge.The £5.5 million building houses over 200 employees, …

News

Parallel trade: is pharma fighting a losing battle?

October 8, 2003
Sales and Marketing ABPI, EU, UK, parallel trade

Parallel trade has become the bete noire of the European pharmaceutical industry, a terrible beast it can only hold at …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026